Review questions metformin's ability to extend lives

04/12/2012 | MedPage Today (free registration)

Metformin treatment did not show any significant effect in cardiovascular or all-cause mortality in diabetes patients, a review in PLoS Medicine found. However, researchers cautioned that their findings were not definitive. Dr. Vivian Fonseca, president for medicine and science at the American Diabetes Association, said many of the studies reviewed lasted a year or less, but eight to 10 years is needed to examine the effectiveness of the drug.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA